Professor Karen Canfell is Director of the Cancer Research Division at Cancer Council NSW and Adjunct Professor at Sydney Medical School, University of Sydney. She holds a D.Phil. (PhD equivalent) in Epidemiology from the University of Oxford. Her work involves the evaluation and translation of new strategies for cancer screening. A focus has been the interplay between HPV vaccination and cervical screening in both high and low resource countries. She has led economic evaluations of new cervical screening approaches for government agencies in several countries and her group’s work also underpins the current Renewal (review) of the National Cervical Screening Program in Australia, which is transitioning to HPV-based screening in 2017. In collaboration with the Victorian Cytology Service, she initiated Compass, which is Australia’s largest clinical trial to assess cervical screening in an HPV-vaccinated population. Her work is now focusing on screening for other cancer types. Her team are involved in evaluating new approaches to breast screening, and she has active projects to quantify the benefits, harms and cost-effectiveness of the National Bowel Cancer Screening Program, to evaluate screening for Lynch Syndrome, and to assess potential new strategies for PSA testing and lung cancer screening. In 2015, Karen received the National Research Excellence Award for the highest-ranked Career Development Fellowship in Population Health and was nominated as one of ‘100 Women of Influence’ in the Westpac/Australian Financial Review national awards